Comparator; mean ± SD | |||||||
---|---|---|---|---|---|---|---|
Study type | Included diagnoses | No. of effect sizes* | No. of patients | No. of controls | Men, % | Age, yr | Study quality |
Case–control studies | |||||||
Anxiety-related disorders47–58,60–92,240 | Panic, generalized anxiety, social anxiety, posttraumatic stress, or obsessive–compulsive disorder, specific phobia | 47 | 1365 | 1469 | 42.039 ± 22.244 | 35.752 ± 5.241 | 11.872 ± 1.907 |
Mood disorders50,68,73,90,93–137 | Major depressive disorder, bipolar disorder | 52 | 2838 | 2882 | 38.031 ± 18.543 | 38.706 ± 7.850 | 11.788 ± 1.775 |
Psychotic disorders73,107,113,138–175 | Schizophrenia, schizoaffective disorder, schizophreniform disorder | 41 | 1713 | 1660 | 57.493 ± 15.080 | 35.127 ± 6.332 | 11.756 ± 1.729 |
Substance dependence disorders159,176–186 | Alcohol, methamphetamine, opioid dependence | 11 | 310 | 415 | 84.836 ± 17.021 | 10.324 ± 5.958 | 11.364 ± 1.748 |
Total | — | 151 | 6226 | 6426 | 47.726 ± 22.637 | 36.933 ± 6.712 | 11.775 ± 1.789 |
Treatment studies | |||||||
Antidepressants†76,83,93,110,116,129,187–201 | Major depressive disorder, panic disorder, generalized anxiety disorder | 31 | 570 | — | 37.981 ± 12.797 | 42.412 ± 6.899 | 11.226 ± 1.892 |
Antipsychotics‡138,141,155,175,202–206 | Schizophrenia | 12 | 262 | — | 57.594 ± 14.892 | 34.668 ± 4.742 | 11.167 ± 1.586 |
Total | — | 43 | 832 | — | 44.342 ± 16.235 | 40.029 ± 7.224 | 11.209 ± 1.794 |
NASSA = noradrenergic and specific serotonergic antidepressant; SD = standard deviation; SNRI = serotonin-norepinephrine reuptake inhibitor; SSRI = selective serotonin reuptake inhibitor; TCA = tricyclic antidepressant.
↵* Number of effect sizes differs from the number of studies included owing to some studies reporting multiple effect sizes for different disorders or subgroups. If studies reported a common control group, effect sizes were adjusted by dividing the number of controls by the number of comparisons made. Subgroups within disorders were pooled where sufficient information was provided for effect size estimates.
↵† Includes NASSA, SNRI, SSRI and TCA.
↵‡ Includes atypical and typical antipsychotics.